Literature DB >> 16793914

The source of APRIL up-regulation in human solid tumor lesions.

P Mhawech-Fauceglia1, G Kaya, G Sauter, T McKee, O Donze, J Schwaller, B Huard.   

Abstract

Abundant mRNA expression for a proliferation-inducing ligand (APRIL) from tumor necrosis factor (TNF) family is observed in many solid tumors. Here, we analyzed in situ the cellular source of APRIL in human solid tumors with anti-APRIL antibodies. In most cases, neutrophils present in the tumor stroma constituted the main source of APRIL. In cutaneous lesions such as melanoma or basal cell carcinoma, tumor-adjacent keratinocytes also produced APRIL. APRIL production by tumor cells themselves was a rare event, only observed in urothelial bladder cancer and squamous cell carcinoma. Detailed analysis revealed that APRIL dissociated from producing cells, and secreted APRIL was retained in the tumor lesions. A direct binding onto tumor cells via heparan sulfate proteoglycans (HSPG) was observed in in vitro experiments and confirmed in situ. Taken together, our analysis indicates a potential role for HSPG/APRIL interactions in the development of solid tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793914     DOI: 10.1189/jlb.1105655

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  32 in total

Review 1.  Neutrophils: key mediators of tumour angiogenesis.

Authors:  Simon Tazzyman; Claire E Lewis; Craig Murdoch
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 2.  The Diverse Biological Functions of Neutrophils, Beyond the Defense Against Infections.

Authors:  Fan Yang; Chang Feng; Xiaodong Zhang; Jun Lu; Yong Zhao
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

3.  Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.

Authors:  Ru Wang; Yichao Guo; Hongzhi Ma; Lin Feng; Qi Wang; Xiaohong Chen; Meng Lian; Haizhou Wang; Jugao Fang
Journal:  Tumour Biol       Date:  2015-09-23

4.  Characterization and biological significance of IL-23-induced neutrophil polarization.

Authors:  Yang Li; Linnan Zhu; Zhulang Chu; Tao Yang; Hai-Xi Sun; Fan Yang; Wei Wang; Yuzhu Hou; Peng Wang; Qingjie Zhao; Yaling Tao; Lianfeng Zhang; Xiaodong Zhang; Yong Zhao
Journal:  Cell Mol Immunol       Date:  2017-07-10       Impact factor: 11.530

5.  APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway.

Authors:  Guihua Wang; Feng Wang; Weifeng Ding; Jingchun Wang; Rongrong Jing; Haiquan Li; Xudong Wang; Yueguo Wang; Shaoqing Ju; Huimin Wang
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

Review 6.  Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.

Authors:  A Sabokbar; D J Mahoney; F Hemingway; N A Athanasou
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

7.  The design and characterization of receptor-selective APRIL variants.

Authors:  Fiona C Kimberley; Almer M van der Sloot; Marco Guadagnoli; Katherine Cameron; Pascal Schneider; J Arnoud Marquart; Miranda Versloot; Luis Serrano; Jan Paul Medema
Journal:  J Biol Chem       Date:  2012-09-07       Impact factor: 5.157

8.  The role of the tumor microenvironment in regulating angiogenesis.

Authors:  Randolph S Watnick
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

9.  APRIL depletion induces cell cycle arrest and apoptosis through blocking TGF-β1/ERK signaling pathway in human colorectal cancer cells.

Authors:  Feng Wang; Lin Chen; Hongbin Ni; Guihua Wang; Weifeng Ding; Hui Cong; Shaoqing Ju; Shumei Yang; Huimin Wang
Journal:  Mol Cell Biochem       Date:  2013-07-20       Impact factor: 3.396

10.  Synovial tissues concentrate secreted APRIL.

Authors:  Cem Gabay; Veit Krenn; Carine Bosshard; Christian Alexander Seemayer; Carlo Chizzolini; Bertrand Huard
Journal:  Arthritis Res Ther       Date:  2009-09-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.